The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. Arthritis Research & Therapy, 21 (1). 164. ISSN 1478-6354

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2019, Pfizer, Inc. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Rheumatoid arthritis, Anti-TNF, Etanercept, Remission, Dose reduction, Withdrawal, DAS28, ACR/EULAR Boolean, CDAI
Dates:
  • Published: 5 July 2019
  • Accepted: 10 June 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 29 Jul 2019 14:55
Last Modified: 29 Jul 2019 14:55
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1186/s13075-019-1937-4
Related URLs:

Share / Export

Statistics